Carpenter Jasmine E, Lee Tiffany, Greene Elizabeth, Holovac Eileen
is a Mental Health Clinical Pharmacy Specialist; is a Geriatric Clinical Pharmacy Specialist; and is a Women's Clinic Psychiatrist; all at the Washington Veterans Affairs Medical Center in the District of Columbia. is an Oncology Clinical Pharmacy Specialist at the Palo Alto Veterans Affairs Medical Center in California.
Fed Pract. 2021 Feb;38(2):62-67. doi: 10.12788/fp.0087.
Suicide is a global phenomenon and is the 10th leading cause of death in the US. Veterans are more likely to die by suicide than those in the general population. In 2018, the suicide rate for all US veterans was 1.5 times higher than the rate for nonveterans, after adjusting for population differences in age and sex. In light of this disparity, suicide prevention is one of the highest priorities for the US Department of Veterans Affairs (VA). One major goal of the VA suicide prevention strategy is to reduce access to lethal means.
This article will provide information on medications with high lethality and a stepwise approach for how health care providers may limit lethal medications for patients at high risk for suicide. The first step is to determine suicide risk. More than 90% of those who die by suicide have a psychiatric diagnosis at the time of death. Clinicians can use risk assessment tools, such as the Veterans Health Administration Suicide Prevention Population Risk Identification and Tracking for Exigencies tool. The second step is to identify substances strongly associated with fatalities. According to the American Association of Poison Control Centers, the pharmaceutical classes associated with the largest number of fatalities are stimulants and street drugs, followed by analgesics, cardiovascular agents, antidepressants, antipsychotics, and sedatives/hypnotics. The third step is to consider potential drug-drug interactions, such as the combination of opioids and sedative-hypnotics. Finally, clinicians need to address risks. With high-risk patients it may be preferential to prescribe medications that are less lethal. All patients with a high risk of suicide should receive lethal means counseling.
While firearms continue to be the most lethal means for veteran suicide, intentional poisoning with medications or substances also is a common method for suicide, especially for female veterans. Having knowledge of medications with high lethality and limiting access to these agents can be a successful strategy for reducing suicide deaths.
自杀是一种全球现象,是美国第十大死因。退伍军人自杀的可能性高于普通人群。2018年,在调整年龄和性别方面的人口差异后,美国所有退伍军人的自杀率比非退伍军人高出1.5倍。鉴于这种差异,预防自杀是美国退伍军人事务部(VA)的最高优先事项之一。VA自杀预防策略的一个主要目标是减少获取致命手段的机会。
本文将提供有关高致死性药物的信息,以及医疗保健提供者如何为自杀高风险患者限制致命药物的逐步方法。第一步是确定自杀风险。超过90%的自杀死亡者在死亡时患有精神疾病诊断。临床医生可以使用风险评估工具,如退伍军人健康管理局自杀预防紧急情况人群风险识别和跟踪工具。第二步是识别与死亡密切相关的物质。根据美国毒物控制中心协会的数据,与死亡人数最多相关的药物类别是兴奋剂和街头毒品,其次是镇痛药、心血管药物、抗抑郁药、抗精神病药和镇静剂/催眠药。第三步是考虑潜在的药物相互作用,如阿片类药物和镇静催眠药的联合使用。最后,临床医生需要应对风险。对于高风险患者,可能更倾向于开处方致死性较低的药物。所有自杀风险高的患者都应接受关于致命手段的咨询。
虽然枪支仍然是退伍军人自杀最致命的手段,但使用药物或物质故意中毒也是一种常见的自杀方式,尤其是对于女性退伍军人。了解高致死性药物并限制获取这些药物可能是减少自杀死亡的成功策略。